Ignite Creation Date:
2024-05-06 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 1:52 PM
Study NCT ID:
NCT04685525
Status:
WITHDRAWN
Last Update Posted:
2024-04-26
First Post:
2020-12-22
Brief Title:
Mycobiome Supporting Diet to Reduce GI Toxicity Associated With ASCT
Sponsor:
Case Comprehensive Cancer Center
Organization:
Case Comprehensive Cancer Center
Study Overview
Official Title:
Mycobiome Supporting Diet MSD to Reduce Gastrointestinal GI Toxicity Associated With Autologous Stem Cell Transplant ASCT For Patients With Multiple Myeloma MM
Status:
WITHDRAWN
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Administrative decision
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine if this specific Mycobiome Supporting Diet MSD diet can help reduce gut inflammation during post-transplant period The MSD is an special diet which will be explained in detail by a dietician that works by supporting the bodys good gut bacteria and fungi
Detailed Description:
This is a non-randomized cohort study Participants will be on a specific diet for 4 weeks prior to transplant and 10 days after transplant and will then be asked to fill out several questionnaires during this period to see if this diet is easy and simple to follow The questionnaires will be weekly while participants are outpatient and once admitted to the hospital participants will need to fill it on the last day 10 days after stem cell infusion Participants will also be requested to provide fecal swab samples which we will test for bacteria and fungi A total of 3 samples will be taken at different time points during this study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None